- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Live Chat: Chronic Fatigue Syndrome—Science and Controversy
21 September 2011 3:36 pm
See below for the chat box. Join us each Thursday at 3 p.m. EST for a live conversation with leading scientists and expert reporters.
Two years ago, Science published a paper suggesting that a mouse retrovirus called XMRV might be involved in chronic fatigue syndrome (CFS), a debilitating disease with no known cause. The study raised worries that XMRV might be spreading via blood donations. Since then, many other studies have failed to find XMRV in CFS patients, and some have suggested that the 2009 paper was the result of lab contamination.
Where does the science stand today? And how has the long and sometimes bitter debate affected the scientific field and CFS patients? Join us for a live chat on this page at 3 p.m. EDT on Thursday, 22 September, to discuss these and other questions with Michael Busch, a transfusion medicine scientist involved in XMRV research, and retrovirologist Jay Levy. You can leave your questions in the comment box below before the chat starts.
Save to my calendar
Michael P. Busch
Michael P. Busch is director of the Blood Systems Research Institute in San Francisco, California. He has led many studies in transfusion medicine and is a member of the Blood XMRV Scientific Research Working Group, a government-funded panel investigating whether XMRV is a risk to the blood supply.
Jay Levy studies HIV/AIDS at the University of California, San Francisco. The main focus of his work is HIV pathogenesis. In July, he published a study in Science that failed to find XMRV in chronic fatigue syndrome patients.